SEATTLE, WA--(Marketwire - April 07, 2008) - Pacific Biometrics, Inc. (OTCBB: PBME) has been awarded two contracts worth a combined $1.6 million with a top multinational pharmaceutical company (the “Sponsor”). These contracts are part of a series of four contracts, two of which were previously announced, related to clinical trials that form part of a global development program for an innovative biological treatment for rheumatoid arthritis (RA), and will provide essential laboratory data for a pivotal Phase III program.
